Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): A randomised, double-blind trial

Yi Long Wu, Jin Soo Lee, Sumitra Thongprasert, Chong Jen Yu, Li Zhang, Guia Ladrera, Vichien Srimuninnimit, Virote Sriuranpong, Jennifer Sandoval-Tan, Yunzhong Zhu, Meilin Liao, Caicun Zhou, Hongming Pan, Victor Lee, Yuh Min Chen, Yan Sun, Benjamin Margono, Fatima Fuerte, Gee Chen Chang, Kasan SeetalaromJie Wang, Ashley Cheng, Elisna Syahruddin, Xiaoping Qian, James Ho, Johan Kurnianda, Hsingjin Eugene Liu, Kate Jin, Matt Truman, Ilze Bara, Tony Mok

Research output: Contribution to journalArticlepeer-review

244 Citations (Scopus)

Fingerprint Dive into the research topics of 'Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): A randomised, double-blind trial'. Together they form a unique fingerprint.

Medicine & Life Sciences